Search

Your search keyword '"Vittecoq D"' showing total 489 results

Search Constraints

Start Over You searched for: Author "Vittecoq D" Remove constraint Author: "Vittecoq D"
489 results on '"Vittecoq D"'

Search Results

3. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH)

4. Combined Bacterial Meningitis and Infective Endocarditis: When Should We Search for the Other When Either One is Diagnosed?

6. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

9. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

10. Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France

12. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

15. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies

16. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

18. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

27. Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

28. Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

30. Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

35. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

39. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

40. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study

44. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

46. Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?

47. Gales graves hospitalisées en dermatologie et maladies infectieuses en Île-de-France : étude multicentrique rétrospective de 83 patients sur 6 ans

48. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)

49. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

Catalog

Books, media, physical & digital resources